Evidence map›Paper›PMID 42404859›Full record

ReviewBreast cancer (Dove Medical Press)2026

Radiomics and Deep Learning: Bridging Breast Cancer Imaging Phenotypes and Genomic Heterogeneity.

Guangming Yi, Lihua Deng, Liping Su, Huan Jie, Cong Huang, Yujun Wang

Abstract readReview
In one paragraph

Review in Breast cancer (Dove Medical Press), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guangming YiDepartment of Oncology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, 621000, People's Republic of China.
Lihua DengDepartment of Radiology, The First People's Hospital of Neijiang, Neijaing, Sichuan, 641000, People's Republic of China.ORCID 0000-0001-5644-1655
Liping SuDepartment of Radiology, Yongchuan Hospital of Chongqing Medical University, Yongchuan, Chongqing, 402160, People's Republic of China.
Huan JieDepartment of Oncology, No. 926 Hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan, 661699, People's Republic of China.
Cong HuangDepartment of Radiology, No. 926 Hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan, 661699, People's Republic of China.ORCID 0000-0003-0105-672X
Yujun WangDepartment of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medicine University (Zhejiang Provincial Hospital of Chinese Medicine), ZheJiang, Hangzhou, 310006, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a highly heterogeneous malignancy. Radiomics, combined with deep learning techniques, harnesses the power of advanced medical imaging to extract rich quantitative features that noninvasively capture tumor imaging phenotypes. This approach facilitates the integration of macroscopic imaging data with genomic heterogeneity, thereby bridging the gap between tumor radiographic appearance and underlying molecular profiles. This review systematically outlines the radiomics workflow in breast cancer, encompassing image acquisition, tumor segmentation, feature extraction, feature selection, and modeling strategies. Emphasis is placed on the role of deep learning in automating feature extraction and enabling multimodal data fusion to enhance predictive accuracy. By examining current research progress, we elucidate methods to uncover latent information related to gene mutations, immune microenvironment characteristics, and other genomic alterations from imaging data. This synthesis highlights the potential of radiogenomics to provide novel insights and tools for precision medicine, ultimately fostering personalized diagnosis, prognosis, and treatment planning in breast cancer care.

Indexed as

breast cancerdeep learninggenomic heterogeneityimaging phenotypesprecision medicineradiogenomicsradiomics

Identifiers

PMID42404859
PMCPMC13332773

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.